Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class A Warrants
April 11, 2019 Off

X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class A Warrants

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the…

Corizon Health Broadens Fight against Opioid Addiction
April 11, 2019 Off

Corizon Health Broadens Fight against Opioid Addiction

By BusinessWire

As the U.S. continues to grapple with solutions to the national opioidaddiction epidemic, Brentwood-based Corizon Health is preparing to offera successful treatment pilot to additional communities the companyserves across the U.S.

April 11, 2019 Off

North America’s $106.9 Million Metagenomics Market, 2027 – Projected to Grow at a CAGR of 8% from 2018 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “North America Metagenomics Market to 2027- Regional Analysis and Forecasts by Product, Application and Country” report has been…

April 11, 2019 Off

Michigan’s Bioscience Community Meets with Legislators During “Bioscience Day at the Capitol”

By BusinessWire

ANN ARBOR, Mich. & LANSING, Mich.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/bioscience?src=hash" target="_blank"gt;#biosciencelt;/agt;–Yesterday, representatives from more than twenty-five Michigan bioscience organizations were joined by…

April 11, 2019 Off

Europe’s $89.7 Million Metagenomics Market, Forecast to 2027: Dominated by Illumina & Qiagen – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Europe Metagenomics Market to 2027 – Regional Analysis and Forecasts by Product, Application and Country” report has been…

April 11, 2019 Off

Median Technologies Reports Full Year 2018 Financial Results

By BusinessWire

Order backlog of €23.7m 2018 full year revenues of €6.3m Cash and cash equivalents of €12.7m, with significantly reduced burn…

April 11, 2019 Off

AmerisourceBergen Ready to Support Transitioning Pharmaceutical Rebates to Point-of-Sale Discounts

By BusinessWire

VALLEY FORGE, Pa.–(BUSINESS WIRE)–AmerisourceBergen, a global healthcare solutions leader, in concert with their industry trade association the Healthcare Distribution Alliance,…

April 11, 2019 Off

Axcella Presents Late-Breaker Data Demonstrating Lead AXA™ Candidate AXA1665 Impacted Markers Related to Liver Health

By BusinessWire

Increased Fischer’s ratio in subjects with mild-moderate hepatic insufficiency Impacted biomarkers of liver-related health Muscle mass maintained, with an impact…

April 11, 2019 Off

Global Basil Essential Oil Market 2019-2023 | Increasing Demand for Organic and Cold-Pressed Basil Essential Oil to Boost Growth | Technavio

By BusinessWire

LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Research?src=hash" target="_blank"gt;#Researchlt;/agt;–The global basil essential oil market is expected to post a CAGR of close to 8% during…

April 11, 2019 Off

Healthcare CMO Market to 2027- Global Analysis & Outlook by Service and Geography – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Healthcare CMO Market to 2027- Global Analysis and Forecasts by Service; and Geography” report has been added to…

Posts pagination

Previous 1 … 5,887 5,888 5,889 … 6,212 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

December 18, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine